Despite how common pediatric pneumonia is, the optimal duration of antibiotic treatment for it has not yet been defined. The Infectious Disease Society of America currently recommends 10 days of treatment for mild pneumonia but they note that this guideline is based on very little evidence. This is an important question to address because determining the proper length of antibiotic treatment for a given condition is extremely important. The goal of this study at CHEO is to determine whether fewer days of antibiotic is an acceptable alternative for the treatment of mild pediatric pneumonia.
Research Projects
-
Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016
30/06/2020
Use of AAP should also be strongly considered in patients with effusions (even if no pathogen is identified), as clinical outcome appears similar to patients treated with broad-spectrum antimicrobials.
-
Epidemiology and Clinical Outcomes of Hospitalizations for Acute Respiratory or Febrile Illness and Laboratory-Confirmed Influenza Among Pregnant Women During Six Influenza Seasons, 2010–2016
01/05/2020
Our findings characterize seasonal influenza hospitalizations among pregnant women and can inform assessments of the public health and economic impact of seasonal influenza on pregnant women.
-
Bronchiectasis in children from Qikiqtani (Baffin) Region, Nunavut, Canada
01/01/2015
Previous researchers have reported that Canadian Inuit children have markedly elevated rates of LRTI early in life. Our study suggests that this may lead to long-term pulmonary sequelae.
Researchers
-
Melanie Buba
Investigator, CHEO Research Institute
-
Deshayne Fell
Affiliate Investigator, CHEO Research Institute
-
Tom Kovesi
Investigator, CHEO Research Institute
